Study guide

9.1 Wound Healing, Surgical Site Infections & Gas Gangrene

Combined Medical Services Examination UPSC CMS

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Structure, Logistics & Pattern

1.1 UPSC CMS Examination Overview & Eligibility 1.2 Two-Paper Written Exam Pattern & Negative Marking 1.3 Personality Test, Service Allocation & Career Paths

2 Chapter 2: General Medicine - Cardiology & Respiratory

2.1 Coronary Artery Disease & Acute Myocardial Infarction 2.2 Heart Failure & Cardiac Arrhythmias 2.3 Community-Acquired Pneumonia & Pulmonary Tuberculosis 2.4 COPD, Bronchial Asthma & Pulmonary Embolism

3 Chapter 3: General Medicine - Gastroenterology & Hepatology

3.1 Peptic Ulcer Disease & Upper GI Bleeding 3.2 Liver Cirrhosis & Portal Hypertension 3.3 Acute & Chronic Viral Hepatitis & Pancreatitis 3.4 Inflammatory Bowel Disease & Malabsorption Syndromes

4 Chapter 4: General Medicine - Nephrology & Endocrinology

4.1 Acute Kidney Injury & Chronic Kidney Disease 4.2 Glomerulonephritis, Nephrotic Syndrome & Electrolyte Imbalances 4.3 Diabetes Mellitus: Diagnosis, Complications & Management 4.4 Thyroid Disorders & Adrenal Gland Dysfunction

5 Chapter 5: General Medicine - Neurology, Haematology & Infection

5.1 Cerebrovascular Accidents (Stroke) & Epilepsy 5.2 Approach to Anaemia: Microcytic, Megaloblastic & Haemolytic 5.3 Acute & Chronic Leukaemias and Lymphomas 5.4 Tropical & Endemic Infections: Malaria, Typhoid & Dengue

6 Chapter 6: General Medicine - Emergency Medicine & Toxicology

6.1 Acute Anaphylaxis, Sepsis & Cardiopulmonary Resuscitation 6.2 Organophosphate, Paracetamol & Snakebite Toxicology 6.3 Common Dermatological & Psychiatric Manifestations in Internal Medicine 6.4 Musculoskeletal System & Adult Rheumatology

7 Chapter 7: Paediatrics - Neonatology & Child Growth

7.1 Newborn Care, Neonatal Resuscitation & APGAR Score 7.2 Prematurity, Low Birth Weight & Neonatal Jaundice 7.3 Infant & Child Growth & Developmental Milestones

8 Chapter 8: Paediatrics - Child Health & Nutrition

8.1 Protein-Energy Malnutrition (PEM) & Micronutrient Deficiencies 8.2 Universal Immunization Programme (UIP) & Child Vaccines 8.3 Pediatric Diarrhoea, Dehydration & Respiratory Emergencies 8.4 Birth Defects, Genetic Counseling, Autism & Paediatric Accidents/Poisoning

9 Chapter 9: Surgery - General Surgery, Wounds & Shock

9.1 Wound Healing, Surgical Site Infections & Gas Gangrene 9.2 Pathophysiology of Shock & Perioperative Fluid Therapy 9.3 Acute Abdomen: Appendicitis, Peritonitis & Intestinal Obstruction 9.4 Classification, Resuscitation & Management of Thermal Burns 9.5 Medicolegal & Ethical Issues in Surgery

10 Chapter 10: Surgery - Surgical Specialties I

10.1 Inguinal, Femoral & Ventral Hernias 10.2 Benign Breast Diseases & Breast Carcinoma 10.3 Solitary Thyroid Nodule & Thyroid Carcinoma 10.4 Benign Prostatic Hyperplasia & Renal Calculi

11 Chapter 11: Surgery - ENT, Orthopaedics & Anaesthesia

11.1 Acute Otitis Media, Tonsillitis & Epistaxis 11.2 Cataract, Glaucoma & Red Eye Emergencies 11.3 Principles of Fracture Management & Common Dislocation 11.4 Principles of Local, Regional & General Anaesthesia 11.5 Neurosurgery: Raised ICP, Head Injury & CNS Lesions 11.6 Thoracic Surgery: Chest Trauma, Pleural & Lung Disease

12 Chapter 12: Obstetrics - Antenatal Care & Complications

12.1 Antenatal Care, Maternal Nutrition & Fetal Assessment 12.2 Preeclampsia, Eclampsia & Gestational Hypertension 12.3 Antepartum Haemorrhage: Placenta Previa & Abruptio Placentae 12.4 Anemia in Pregnancy & Gestational Diabetes Mellitus 12.5 Spontaneous & Recurrent Abortion: Recognition & Management

13 Chapter 13: Obstetrics & Gynaecology - Labor & PPH

13.1 Normal Labor Mechanisms & Partograph Monitoring 13.2 Malpresentations, Breech & Obstructed Labor 13.3 Postpartum Haemorrhage (PPH) Causes & Management 13.4 Puerperal Sepsis & Postnatal Maternal Care

14 Chapter 14: Gynaecology & Family Planning

14.1 Abnormal Uterine Bleeding & Uterine Fibroids 14.2 Cervical Screening (Pap Smear) & Pelvic Inflammatory Disease 14.3 Temporary & Permanent Contraceptive Methods in India 14.4 Medical Termination of Pregnancy (MTP): Law & Methods

15 Chapter 15: PSM - Epidemiology & Biostatistics

15.1 Principles of Epidemiology & Disease Transmission 15.2 Observational & Experimental Epidemiological Study Designs 15.3 Evaluation of Screening Tests: Sensitivity, Specificity & Predictive Value 15.4 Biostatistics: Sampling, Central Tendency & Significance Testing

16 Chapter 16: PSM - Disease Epidemiology & Programmes

16.1 Epidemiology & Control of TB, Malaria & Dengue 16.2 National Tuberculosis Elimination Programme & NVBDCP 16.3 Epidemiology of Hypertension, Diabetes & Cancer in India 16.4 Cold Chain Management & Vaccine Logistics in India 16.5 Genetics and Health: Inheritance, Screening & Counseling

17 Chapter 17: PSM - Health Planning & Environmental Health

17.1 Demography, Fertility Rates & Family Welfare Indicators 17.2 Safe Water Supply, Waste Disposal & Air Pollution 17.3 Occupational Health Hazards & Pneumoconioses 17.4 Health Care Delivery System, Ayushman Bharat & National Health Mission 17.5 International Health: WHO, Global Agencies & SDG 3 17.6 Medical Sociology & Health Education

9.1 Wound Healing, Surgical Site Infections & Gas Gangrene

Key Takeaways Explain This Topic AI

Wound healing progresses through three sequential, overlapping phases: Hemostasis/Inflammation (Days 0-4), Proliferation/Granulation (Days 4-21), and Remodeling/Maturation (Day 21 to 1 year), transitioning collagen from Type III to Type I to achieve up to 80% original tensile strength.

Primary intention healing involves clean surgical closure with minimal scar; Secondary intention occurs via granulation and myofibroblast contraction; Tertiary intention (delayed primary closure) manages contaminated wounds left open for 4-5 days before surgical closure.

Surgical Site Infections (SSIs) are classified by CDC into Superficial Incisional, Deep Incisional, and Organ/Space, with Staphylococcus aureus as the predominant pathogen overall and enteric anaerobes/coliforms dominating lower gastrointestinal procedures.

Gas Gangrene (clostridial myonecrosis) is caused primarily by Clostridium perfringens producing alpha-toxin (lecithinase), presenting with rapid dishwater discharge, crepitus, severe pain, and systemic hemolysis requiring urgent surgical debridement and IV antibiotics.

Systemic factors impairing wound healing (malnutrition, hypovitaminosis C, zinc deficiency, diabetes, steroids) can be partially counteracted, such as using Vitamin A to restore TGF-beta expression impaired by corticosteroids.

Last updated: July 2026

9.1 Wound Healing, Surgical Site Infections & Gas Gangrene

UPSC CMS High-Yield Core Focus: Mastery of wound healing phases, cell types involved, collagen subtype transitions, local and systemic factors impairing healing, CDC classification of surgical site infections (SSIs), antibiotic prophylaxis timing, and the emergency surgical management of clostridial myonecrosis (gas gangrene).

1. Phases of Normal Wound Healing

Wound healing is a complex, dynamic physiological cascade organized into three overlapping phases: Hemostasis & Inflammation , Proliferation , and Remodeling & Maturation .

Phase 1: Hemostasis and Inflammation (Days 0 – 4)

Immediate Hemostasis: Injury disrupts blood vessels, exposing subendothelial collagen. Platelets aggregate, activating the intrinsic and extrinsic coagulation cascades to form a fibrin-fibronectin clot. Platelets release key alpha-granule growth factors: Platelet-Derived Growth Factor (PDGF) and Transforming Growth Factor-beta (TGF-β) .

Neutrophil Infiltration (24 – 48 hours): Vasodilation and increased capillary permeability (mediated by histamine, serotonin, and prostaglandins) allow polymorphonuclear neutrophils (PMNs) to marginate and migrate into the wound matrix. Neutrophils phagocytose bacteria and debris via reactive oxygen species and lysosomal enzymes.

Macrophage Arrival (48 – 72 hours): Monocytes differentiate into macrophages upon entering the wound. Macrophages are the indispensable orchestrators of wound healing. They clear remaining debris and secrete essential cytokines: PDGF, TGF-β, Fibroblast Growth Factor (FGF), and Vascular Endothelial Growth Factor (VEGF), which recruit fibroblasts and stimulate endothelial cell proliferation.

Phase 2: Proliferation and Granulation (Days 4 – 21)

Fibroplasia & Matrix Synthesis: Fibroblasts migrate into the wound along the fibronectin scaffold under the influence of PDGF and TGF-β. Fibroblasts synthesize extracellular matrix components, predominantly Type III collagen (immature, thin, non-cross-linked collagen).

Neovascularization (Angiogenesis): Endothelial cells proliferate in response to VEGF and basic FGF, forming delicate new capillary loops that impart a granular, red appearance ( granulation tissue ).

Epithelialization: Basal keratinocytes from wound margins and epidermal appendages (hair follicles, sweat glands) migrate across the granulation tissue to restore epidermal integrity.

Wound Contraction: Differentiated myofibroblasts (containing alpha-smooth muscle actin) exert mechanical traction, pulling wound edges inward to decrease overall surface area.

Phase 3: Remodeling and Maturation (Day 21 – 1 Year)

Collagen Subtype Transition: Matrix Metalloproteinases (MMPs) secreted by fibroblasts degrade weak Type III collagen, which is systematically replaced by dense, organized Type I collagen oriented along lines of mechanical stress (Langer's lines).

Tensile Strength Accumulation: At 3 weeks, wound tensile strength is only ~20% of normal skin. Remodeling increases strength over 6 to 12 months, reaching a maximum plateau of 70–80% of original, uninjured skin strength . Scar tissue never achieves 100% of original tensile strength.

2. Modes of Wound Closure (Intention)

Mode of Closure Mechanism & Characteristics Clinical Examples

Primary Intention (First Intention) Surgical apposition of clean wound edges using sutures, staples, or adhesive tape. Minimal tissue loss, minimal granulation tissue, rapid epithelialization, minimal scarring. Clean surgical incisions (e.g., thyroidectomy, elective hernia repair).

Secondary Intention Wound left open to heal spontaneously from the base upward by granulation tissue formation, myofibroblast contraction, and re-epithelialization. Significant tissue loss, prolonged healing, prominent scarring. Excisional wounds, severe abscess cavities, pressure ulcers, infected wounds.

Tertiary Intention (Delayed Primary Closure) Heavily contaminated or dirty wound initially cleaned, debrided, and left open under sterile packing for 4–5 days. Once granulation tissue forms without active infection, surgical closure is performed. Perforated appendicitis incisions, dirty traumatic lacerations, human/animal bites.

  • 3. Factors Impairing Wound Healing
  • Systemic Factors

Malnutrition & Hypoproteinemia: Protein deficiency impairs fibroblast proliferation and collagen synthesis. Serum albumin <3.0 g/dL significantly increases wound dehiscence risk.

Vitamin Deficiencies:

Vitamin C (Ascorbic Acid): Essential cofactor for prolyl and lysyl hydroxylase. Deficiency (scurvy) prevents triple-helix collagen stabilization, leading to unformed collagen and wound breakdown.

Vitamin A: Promotes epithelialization and fibronectin synthesis. Reverses the inhibitory effects of systemic corticosteroids on wound healing.

Zinc Deficiency: Impairs DNA synthesis, cell division, and MMP activity.

Diabetes Mellitus: Microvascular disease causes tissue hypoxia; hyperglycemia impairs neutrophil chemotaxis, phagocytosis, and collagen cross-linking.

Systemic Corticosteroids: Inhibit macrophage activation, TGF-β release, collagen synthesis, and wound contraction.

Jaundice & Uremia: High bilirubin levels and nitrogenous wastes blunt cellular immune response and collagen deposition.

Local Factors

Tissue Ischemia & Hypoxia: Inadequate blood supply (arterial disease, excessive suture tension, localized edema).

Infection: Bacterial load > 10 5 10^5 1 0 5 organisms per gram of tissue disrupts healing by prolonging inflammation and destroying extracellular matrix via bacterial proteases.

Foreign Material & Necrotic Tissue: Serves as a nidus for infection and physical barrier to healing.

Ionizing Radiation: Induces endarteritis obliterans, causing permanent tissue ischemia and fibrosis.

4. Pathological Scarring: Hypertrophic Scars vs. Keloids

Feature Hypertrophic Scar Keloid

Anatomical Extent Confined strictly within the boundaries of the original wound incision Extends beyond original wound margins into surrounding normal tissue

Onset Develops early (within 4–8 weeks post-injury) Develops late (months to years post-injury)

Histology Organized, parallel bundles of Type III collagen Disorganized, thick, acellular collagen bundles (Type I and III)

Genetic & Racial Predisposition Equal across all races; no strong genetic link Higher incidence in dark-skinned individuals (African, Asian); familial tendency

Anatomical Sites Flexor surfaces, across joint lines, sternum Earlobes, deltoid region, presternal area, upper back

Natural History Frequently regresses spontaneously over 1–2 years Rarely regresses spontaneously; recurs after surgical excision alone

Treatment Protocol Pressure therapy, silicone gel sheeting, intralesional triamcinolone Intralesional triamcinolone acetonide, silicone sheets, excision + radiotherapy

5. Surgical Site Infections (SSIs)

According to the Centers for Disease Control and Prevention (CDC), SSIs are categorized by anatomical depth and must occur within 30 days of surgery (or within 90 days if a permanent surgical implant is placed).

CDC Classification of SSIs

Superficial Incisional SSI: Involves only skin and subcutaneous tissue. Symptoms: Purulent drainage, localized pain, warmth, erythema, or positive culture.

Deep Incisional SSI: Involves deep soft tissues (fascia and muscle layers). Symptoms: Deep purulent drainage, spontaneous dehiscence, or deep abscess on clinical/radiological exam.

Organ/Space SSI: Involves any anatomical space opened or manipulated during the operation (e.g., intra-abdominal abscess, subphrenic collection, empyema).

Surgical Wound Classification & Infection Risk

Clean Wounds (1–2% SSI Risk): Uninfected operative wound; no inflammation encountered; respiratory, GI, and GU tracts NOT entered. Examples: Elective thyroidectomy, inguinal hernia repair, mastectomy.

Clean-Contaminated Wounds (2–10% SSI Risk): Operative wound in which respiratory, GI, or GU tracts are entered under controlled conditions without unusual contamination. Examples: Elective cholecystectomy, elective gastrectomy, appendectomy without perforation.

Contaminated Wounds (10–20% SSI Risk): Open, fresh traumatic wounds; operations with major breaks in sterile technique or gross spillage from GI tract. Examples: Acute non-perforated appendicitis, open fracture within 4 hours.

Dirty / Infected Wounds (>20% SSI Risk): Old traumatic wounds with retained devitalized tissue; existing clinical infection or perforated viscus. Examples: Perforated appendicitis with fecal peritonitis, diverticular abscess.

Antibiotic Prophylaxis Guidelines

Timing: Single IV dose administered within 60 minutes prior to skin incision (within 120 minutes for vancomycin or fluoroquinolones) to ensure peak tissue drug concentration during incision.

Agent Selection: First- or second-generation cephalosporin (e.g., Cefazolin IV) for clean/clean-contaminated procedures; add Metronidazole for colorectal surgery.

Redosing: Re-dose intraoperatively if procedure duration exceeds 2 half-lives of the antibiotic (e.g., >3–4 hours for Cefazolin) or if blood loss exceeds 1,500 mL.

  • 6. Gas Gangrene (Clostridial Myonecrosis)
  • Etiology & Pathophysiology

Causative Organism: Clostridium perfringens (Type A), an obligate anaerobic, spore-forming Gram-positive bacillus, accounts for 80–90% of cases. Other species include C. septicum and C. novyi .

Predisposing Factors: Deep crush injuries, high-velocity gunshot wounds, soil-contaminated compound fractures, or ischemic surgical stumps.

Toxin Mechanism: C. perfringens produces Alpha-toxin (a lecithinase / phospholipase C) that cleaves cell membrane phospholipids, causing widespread necrosis of muscle cells, red blood cell lysis (intravascular hemolysis), and microvascular thrombosis leading to extensive tissue ischemia.

Clinical Presentation

Rapid Onset: Symptoms develop rapidly, typically within 12 to 48 hours post-injury.

Symptoms & Signs:

Sudden, severe, excruciating wound pain out of proportion to physical appearance.

Pale, tense, edematous skin that rapidly transitions to a dark reddish-purple or bronze discoloration with dirty bullae.

Profuse, thin, brownish, foul-smelling discharge described as "dishwater fluid" .

Soft tissue crepitus (palpable gas pockets in muscle planes and subcutis).

Systemic Toxicity: Marked tachycardia, high fever, jaundice (secondary to intravascular hemolysis), profound hypotension, and rapid progression to septic shock and multi-organ failure.

Diagnosis & Emergency Surgical Protocol

Microbiology: Gram stain of discharge reveals large, Gram-positive, boxcar-shaped bacilli with a conspicuous absence of polymorphonuclear leukocytes (destroyed by clostridial toxins).

Radiology: Soft tissue plain radiograph or CT demonstrates extensive gas feathery dissecting along fascial and muscle planes.

Emergency Surgical Management:

Immediate Radical Surgical Debridement: Emergency longitudinal fasciotomies and excision of all necrotic, non-viable muscle tissue until healthy, contractile, bleeding muscle is reached. Amputation may be life-saving for gangrenous limbs.

High-Dose Antimicrobial Therapy: Intravenous Benzylpenicillin (3–4 million units IV every 4 hours) combined with Clindamycin (600–900 mg IV every 8 hours; clindamycin suppresses bacterial toxin synthesis).

Adjuvant Hyperbaric Oxygen Therapy (HBO): High arterial oxygen tension inhibits anaerobic clostridial growth and inactivates alpha-toxin production.

Aggressive Resuscitation: ICU admission for fluid resuscitation, blood transfusion for hemolysis, and hemodynamic vasopressor support.

Loading diagram... Clinical Pathway for Surgical Site Infection and Wound Management